Shicheng Su

8.7k total citations · 8 hit papers
53 papers, 6.3k citations indexed

About

Shicheng Su is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Shicheng Su has authored 53 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Immunology, 20 papers in Oncology and 19 papers in Molecular Biology. Recurrent topics in Shicheng Su's work include Immune cells in cancer (10 papers), Cancer-related molecular mechanisms research (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Shicheng Su is often cited by papers focused on Immune cells in cancer (10 papers), Cancer-related molecular mechanisms research (8 papers) and Cancer Immunotherapy and Biomarkers (8 papers). Shicheng Su collaborates with scholars based in China, United States and Hong Kong. Shicheng Su's co-authors include Erwei Song, Qiang Liu, Di Huang, Herui Yao, Fengxi Su, Yue Xing, Linbin Yang, Jianing Chen, Jiaqian Li and Jianing Chen and has published in prestigious journals such as Nature, Cell and Nature Communications.

In The Last Decade

Shicheng Su

48 papers receiving 6.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness

2018 921 citations Shicheng Su, Jianing Chen et al. Cell profile →
DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25

2020 689 citations Linbin Yang, Qiang Liu et al. Nature profile →
A Positive Feedback Loop between Mesenchymal-like Cancer Cells and Macrophages Is Essential to Breast Cancer Metastasis

2014 609 citations Shicheng Su, Qiang Liu et al. Cancer Cell profile →
Extracellular vesicle-packaged HIF-1α-stabilizing lncRNA from tumour-associated macrophages regulates aerobic glycolysis of breast cancer cells

2019 581 citations Jianing Chen, Linbin Yang et al. Nature Cell Biology profile →
CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3

2011 507 citations Yandan Yao, Fengyan Yu et al. Cancer Cell profile →
NKILA lncRNA promotes tumor immune evasion by sensitizing T cells to activation-induced cell death

2018 345 citations Di Huang, Linbin Yang et al. Nature Immunology profile →
Targeting Mitochondria-Located circRNA SCAR Alleviates NASH via Reducing mROS Output

2020 337 citations Qiyi Zhao, Ruiying Ma et al. Cell profile →
Tumour circular RNAs elicit anti-tumour immunity by encoding cryptic peptides

2023 116 citations Di Huang, Jian‐You Liao et al. Nature profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shicheng Su China	29	3.1k	2.5k	2.4k	2.2k	677	53	6.3k
Jörg Wischhusen Germany	41	2.7k 0.9×	2.3k 0.9×	2.6k 1.1×	1.4k 0.6×	443 0.7×	91	6.7k
Neta Erez Israel	35	2.6k 0.8×	1.9k 0.8×	3.1k 1.3×	1.4k 0.6×	710 1.0×	61	5.7k
Christian Stockmann Germany	28	2.0k 0.6×	2.3k 0.9×	1.7k 0.7×	1.6k 0.7×	613 0.9×	35	5.3k
Muhammad Zaeem Noman France	36	2.4k 0.8×	3.0k 1.2×	2.6k 1.1×	2.3k 1.0×	653 1.0×	65	6.5k
Meriem Hasmim France	28	1.5k 0.5×	2.1k 0.9×	2.2k 0.9×	1.5k 0.7×	536 0.8×	42	4.6k
Andrew D. Rhim United States	29	2.4k 0.8×	1.5k 0.6×	4.5k 1.9×	1.6k 0.7×	567 0.8×	68	6.5k
Lukas J.A.C. Hawinkels Netherlands	31	1.9k 0.6×	1.6k 0.7×	2.1k 0.9×	895 0.4×	590 0.9×	99	4.8k
Mikhail Binnewies United States	14	2.6k 0.9×	4.5k 1.8×	3.9k 1.6×	1.0k 0.5×	1.0k 1.5×	20	8.1k
Sandra S. McAllister United States	24	2.3k 0.7×	1.1k 0.5×	2.8k 1.2×	1.2k 0.5×	1.1k 1.6×	46	5.1k
Yangqiu Li China	36	2.2k 0.7×	2.2k 0.9×	2.2k 0.9×	1.1k 0.5×	319 0.5×	294	5.5k

Countries citing papers authored by Shicheng Su

Since Specialization

Citations

This map shows the geographic impact of Shicheng Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shicheng Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shicheng Su more than expected).

Fields of papers citing papers by Shicheng Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shicheng Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shicheng Su. The network helps show where Shicheng Su may publish in the future.

Co-authorship network of co-authors of Shicheng Su

This figure shows the co-authorship network connecting the top 25 collaborators of Shicheng Su. A scholar is included among the top collaborators of Shicheng Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shicheng Su. Shicheng Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wu, Longfei, Jing Li, Wenping Li, et al.. (2025). Intestinal taurine acts as a novel immunometabolic modulator of IBD by degrading redundant mitochondrial RNA. Cellular and Molecular Immunology. 22(11). 1398–1413.

Bi, Aiwei, Wen‐Tao Deng, Di Huang, & Shicheng Su. (2024). Circular RNAs and their encoded cryptic peptides: Frontier in tumor vaccines. Chinese Science Bulletin (Chinese Version). 69(33). 4787–4788.

Liu, Xinwei, Yingying Ye, Xiaoyun Xiao, et al.. (2023). Niche stiffness sustains cancer stemness via TAZ and NANOG phase separation. Nature Communications. 14(1). 238–238. 58 indexed citations

Di, Can, Shi‐Jian Song, Yubo Zhang, et al.. (2023). Choroid plexus mast cells drive tumor-associated hydrocephalus. Cell. 186(26). 5719–5738.e28. 21 indexed citations

Li, Jiaqian, Di Huang, Bingxi Lei, et al.. (2022). VLA-4 suppression by senescence signals regulates meningeal immunity and leptomeningeal metastasis. eLife. 11. 7 indexed citations

Liu, Jieqiong, Ying Wang, Zhenluan Tian, et al.. (2022). Multicenter phase II trial of Camrelizumab combined with Apatinib and Eribulin in heavily pretreated patients with advanced triple-negative breast cancer. Nature Communications. 13(1). 3011–3011. 67 indexed citations

Huang, Di, Xueman Chen, Xin Zeng, et al.. (2021). Targeting regulator of G protein signaling 1 in tumor-specific T cells enhances their trafficking to breast cancer. Nature Immunology. 22(7). 865–879. 71 indexed citations

Lu, Yiwen, Yi-Jiao Huang, Li Jiang, et al.. (2021). Eosinophil extracellular traps drive asthma progression through neuro-immune signals. Nature Cell Biology. 23(10). 1060–1072. 86 indexed citations

Yang, Linbin, Qiang Liu, Xiaoqian Zhang, et al.. (2020). DNA of neutrophil extracellular traps promotes cancer metastasis via CCDC25. Nature. 583(7814). 133–138. 689 indexed citations breakdown →

10.

Zhou, Liyan, Meng Ren, Tingting Zeng, et al.. (2019). TET2-interacting long noncoding RNA promotes active DNA demethylation of the MMP-9 promoter in diabetic wound healing. Cell Death and Disease. 10(11). 813–813. 53 indexed citations

11.

Wang, Ying, Jianing Chen, Linbin Yang, et al.. (2018). Tumor-Contacted Neutrophils Promote Metastasis by a CD90-TIMP-1 Juxtacrine–Paracrine Loop. Clinical Cancer Research. 25(6). 1957–1969. 70 indexed citations

12.

Li, Huiping, Jiang Liu, Jianing Chen, et al.. (2018). A serum microRNA signature predicts trastuzumab benefit in HER2-positive metastatic breast cancer patients. Nature Communications. 9(1). 1614–1614. 84 indexed citations

13.

Su, Shicheng, Jinghua Zhao, Yue Xing, et al.. (2018). Immune Checkpoint Inhibition Overcomes ADCP-Induced Immunosuppression by Macrophages. Cell. 175(2). 442–457.e23. 230 indexed citations

14.

Nie, Yan, Jianing Chen, Di Huang, et al.. (2017). Tumor-Associated Macrophages Promote Malignant Progression of Breast Phyllodes Tumors by Inducing Myofibroblast Differentiation. Cancer Research. 77(13). 3605–3618. 43 indexed citations

15.

Su, Shicheng, Jian‐You Liao, Jiang Liu, et al.. (2017). Blocking the recruitment of naive CD4+ T cells reverses immunosuppression in breast cancer. Cell Research. 27(4). 461–482. 173 indexed citations

16.

Huang, Di, Shicheng Su, Xiuying Cui, et al.. (2014). Nerve Fibers in Breast Cancer Tissues Indicate Aggressive Tumor Progression. Medicine. 93(27). e172–e172. 63 indexed citations

17.

Su, Shicheng, Wei Wu, Chonghua He, Qiang Liu, & Erwei Song. (2014). Breaking the vicious cycle between breast cancer cells and tumor-associated macrophages. OncoImmunology. 3(8). e953418–e953418. 25 indexed citations

18.

Tang, Wei, Jiujun Zhu, Shicheng Su, et al.. (2012). MiR-27 as a Prognostic Marker for Breast Cancer Progression and Patient Survival. PLoS ONE. 7(12). e51702–e51702. 114 indexed citations

19.

Chen, Jingqi, Yandan Yao, Fengyan Yu, et al.. (2011). CCL18 from Tumor-Associated Macrophages Promotes Breast Cancer Metastasis via PITPNM3. Cancer Cell. 19(6). 814–816. 18 indexed citations

20.

Zhang, Xilong, Kaisheng Yin, Hong Wang, & Shicheng Su. (2005). Serum Adiponectin Levels in Adult Male Patients with Obstructive Sleep Apnea Hypopnea Syndrome. Respiration. 73(1). 73–77. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact